Ginkgo Bioworks

Ginkgo Bioworks

Ginkgo Bioworks is a biotechnology company using machine learning techniques and lab automation to engineer microorganisms as a service.

All edits by  David Hao 

Edits on 1 May, 2019
David Hao
David Hao approved a suggestion from Golden's AI on 1 May, 2019
Edits made to:
Article (+13/-13 characters)

On July 16th, 2014 Ginkgo Bioworks received $120K in seed funding from Y Combinator, TSVC, CRCM venturesCRCM ventures, 11.2 Capital, Farzad Nazem, Todd Corenson, and David Spector.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.